CCTN/CHFS RESEARCH COMPETITION

Friday, October 27, 2023

09:45 – 10:45 EST

Location: Palais, 513DEF

Co-Chair(s)

Phyllis Billia, MD, PhD, FRCPC

Clinician Scientist
CCS, CCTN, CHFS, CANCARE
Toronto General Research Institute
CM

Caroline McGuinty, MD FRCPC

Cardiologist
CCS, CCTN
University of Ottawa

Presenter(s)

Kim Anderson, MD (she/her/hers)

Assistant Professor
CHFS, CCTN
Dalhousie University
Kim Connelly, MBBS, PhD (he/him/his)

Executive Director, Keenan Research Center & Division Head, Cardiology
St.Michael's Hospital, Unity Health Toronto
University of Toronto
Jacob Udell, MD, MPH

Cardiology Division Head
Women's College Hospital
University of Toronto

Disclosure(s):

Phyllis Billia, MD, PhD, FRCPC: Abbott Laboratories: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Caroline M. McGuinty, MD FRCPC: Astra Zeneca: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novartis: Speaker/Honoraria (Ongoing); Pallium Canada: Speaker/Honoraria (Ongoing)

Kim A. Connelly, MBBS, PhD: Abbott: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); AstraZeneca: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Merck: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Novartis: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); NovoNordisk: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Servier: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Jacob A. Udell, MD, MPH: Boehringer Ingelheim: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Janssen: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novovax: Consultant/Advisory Board (Terminated, December 8, 2022); Sanofi: Consultant/Advisory Board (Terminated, May 16, 2022)

Presentations:

09:45 – 10:00 EST

EXTERNAL VALIDATION OF AI PRIMARY GRAFT DYSFUNCTION PREDICTION CALCULATOR
Presenter: Ismail R. Raslan – UHN
10:00 – 10:15 EST

FUNCTIONAL ROLE OF INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS (IP3RS) IN THE REGULATION OF CARDIAC MYOFIBROBLASTS
Presenter: Urna Kansakar, PhD – Albert Einstein College of Medicine
10:15 – 10:30 EST

HEART FAILURE IMPAIRS BONE MARROW HEMATOPOIETIC STEM CELL FUNCTION AND RESPONSES TO INJURY
Presenter: Tina Marvasti, MD, PhD – University of Toronto
10:30 – 10:45 EST

IMPACT OF HEMOGLOBIN LEVEL IN EX VIVO HEART PERFUSION ON DONATION AFTER CIRCULATORY DEATH HEARTS: A JUVENILE PORCINE EXPERIMENTAL MODEL.
Presenter: Yasuyuki Kobayashi, MD, PhD